IP Verse

Sangamo Biosciences competitive analysis

Latest publications and patents of Sangamo Biosciences New

Explore the latest publications and patents granted to Sangamo Biosciences, showcasing their recent innovations and technological advancements.

Last updated on: Sep 28, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Sangamo Biosciences
EP3196301	Oct 17, 2018	Methods And Compositions For The Treatment Of Monogenic Diseases	Revoked
EP1651660	Jan 24, 2018	Methods And Compositions For Targeted Cleavage And Recombination	No Opposition Filed Within Time Limit
EP2419511	Jan 17, 2018	Targeted Integration Into Stem Cells	No Opposition Filed Within Time Limit
EP2344660	Jan 17, 2018	Methods And Compositions For Inactivating Glutamine Synthetase Gene Expression	No Opposition Filed Within Time Limit

Latest patents of Sangamo Biosciences opposed by its competitors

Explore Sangamo Biosciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3196301	Oct 17, 2018	Methods And Compositions For The Treatment Of Monogenic Diseases	3

Latest PTAB cases involving Sangamo Biosciences

Discover the latest PTAB cases involving Sangamo Biosciences, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sangamo Biosciences with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
SANGAMO BIOSCIENCES	-	3	-	-	Non-Active
LEEMING	13	-	-	-	Highly Aggressive
MATHYS & SQUIRE	49	-	-	-	Highly Aggressive
PATENT BOUTIQUE	43	-	-	-	Highly Aggressive